Compare · AMED vs LHCG
AMED vs LHCG
Side-by-side comparison of Amedisys Inc (AMED) and LHC Group (LHCG): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AMED and LHCG operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- AMED is the larger of the two at $4.20B, about 1.1x LHCG ($3.72B).
- AMED has more recent analyst coverage (25 ratings vs 21 for LHCG).
- Company
- Amedisys Inc
- LHC Group
- Price
- $100.98-0.00%
- $169.80+0.47%
- Market cap
- $4.20B
- $3.72B
- 1M return
- +3.66%
- -
- 1Y return
- +7.54%
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2005
- News (4w)
- 0
- 0
- Recent ratings
- 25
- 21
Amedisys Inc
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. As of December 31, 2020, the company owned and operated 320 home health care centers, 180 hospice care centers, and 14 personal-care care centers in 39 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
LHC Group
LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company's Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services. Its Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. The company's Home and Community-Based Services segment offers range of services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand services to patients in their home or in a medical facility. Its Facility-Based Services segment serves patients suffering from respiratory failure, neuromuscular and cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments; and operates institutional pharmacy and other non-related facilities, nursing facilities, family health center, rural health clinic, and physician practice, as well as offers physical therapy services. The company's Healthcare Innovations (HCI) Services segment provides strategic health management services to accountable care organizations. As of December 31, 2020, it operated 537 home health services locations, 120 hospice locations, 124 community-based service locations, 11 long-term acute care hospitals with 12 locations, and 12 HCI locations. The company was founded in 1994 and is based in Lafayette, Louisiana.
Latest AMED
- SEC Form 15-12G filed by Amedisys Inc
- Twilio Set to Join S&P MidCap 400
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
- SEC Form S-8 POS filed by Amedisys Inc
Latest LHCG
- SEC Form 4: Reed W Earl Iii returned $23,595,490 worth of shares to the company (138,797 units at $170.00), closing all direct ownership in the company
- SEC Form 4: Nixon Ronald T returned $4,607,000 worth of shares to the company (27,100 units at $170.00), closing all direct ownership in the company
- SEC Form 4: Azare Monica F returned $5,185,000 worth of shares to the company (30,500 units at $170.00), closing all direct ownership in the company
- SEC Form 4: Goldberg Jonathan returned $9,770,240 worth of shares to the company (57,472 units at $170.00), closing all direct ownership in the company
- SEC Form 4: Mackel Dale returned $3,066,630 worth of shares to the company (18,039 units at $170.00), closing all direct ownership in the company
- SEC Form 4: Indest John L returned $5,941,160 worth of shares to the company (34,948 units at $170.00), closing all direct ownership in the company
- SEC Form 4: Gachassin Nicholas Iii returned $2,696,200 worth of shares to the company (15,860 units at $170.00), closing all direct ownership in the company
- SEC Form 4: Proffitt Joshua L. returned $7,809,290 worth of shares to the company (117,443 units at $66.49), closing all direct ownership in the company
- SEC Form 4: Myers Keith G returned $136,814,640 worth of shares to the company (903,558 units at $151.42), closing all direct ownership in the company
- SEC Form 4: Seymour Kimberly S returned $264,180 worth of shares to the company (5,595 units at $47.22), closing all direct ownership in the company